Fracture Risk Prediction in CKD: Comparing Bone Turnover Markers and Bone Mineral Density (BMD) Performance in Dialysis and Nondialysis Populations

Background: Bone mineral density (BMD) is a recognized predictor of fracture risk in the general population, but its utility in patients with chronic kidney disease (CKD) remains uncertain due to heterogeneous bone turnover. This study evaluated the prognostic value of BMD and bone turnover markers (BTMs)—parathyroid hormone (PTH), C-terminal telopeptide of type I collagen (CTX), and bone-specific alkaline phosphatase (bone ALP)—for fracture risk in CKD patients, both with and without dialysis. Methods: We retrospectively analyzed 853 adult patients with CKD who underwent BMD and BTM assessments between 2010 and 2024. Patients were stratified by dialysis status (RRT: n=514; non-RRT: n=339). Cox proportional hazards models adjusted for clinical covariates were used to assess fracture risk across tertiles of each marker and BMD category. Time-dependent receiver operating characteristic (ROC) curves were used to compare predictive performance for 5-year fracture risk. Results: Fracture risk did not differ significantly across tertiles of PTH, CTX, or bone ALP in either RRT or non-RRT groups. Spline analysis likewise demonstrated no meaningful nonlinear associations. In contrast, BMD was significantly associated with fracture risk in both groups: patients with osteoporosis (T-score ≤ −2.5) had markedly elevated risk in the RRT (adjusted HR 17.7, 95% CI 2.24–2288.2) and non-RRT (HR 14.5, 95% CI 1.80–1885.3) groups. Time-dependent ROC analysis confirmed the superior predictive performance of BMD over BTMs for 5-year fracture risk, with AUCs of 0.712 (RRT) and 0.641 (non-RRT). No BTM outperformed BMD in either group. Conclusion: BMD was a strong predictor of fracture risk in CKD patients, regardless of dialysis status. In contrast, bone turnover markers were not associated with fracture risk. These results support the role of BMD assessment in fracture risk evaluation in CKD.Time-dependent ROC Curves for 5-year fracture risk prediction in RRT (left) and non-RRT (right) patients.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025mbfxek7j
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fracture Risk Prediction in CKD: Comparing Bone Turnover Markers and Bone Mineral Density (BMD) Performance in Dialysis and Nondialysis Populations

Ji Eun Kim
Journal of the American Society of Nephrology
Bone health and osteoporosis research
article

Fracture Risk Prediction in CKD: Comparing Bone Turnover Markers and Bone Mineral Density (BMD) Performance in Dialysis and Nondialysis Populations

Ji Eun Kim
article en

Abstract

Background: Bone mineral density (BMD) is a recognized predictor of fracture risk in the general population, but its utility in patients with chronic kidney disease (CKD) remains uncertain due to heterogeneous bone turnover. This study evaluated the prognostic value of BMD and bone turnover markers (BTMs)—parathyroid hormone (PTH), C-terminal telopeptide of type I collagen (CTX), and bone-specific alkaline phosphatase (bone ALP)—for fracture risk in CKD patients, both with and without dialysis. Methods: We retrospectively analyzed 853 adult patients with CKD who underwent BMD and BTM assessments between 2010 and 2024. Patients were stratified by dialysis status (RRT: n=514; non-RRT: n=339). Cox proportional hazards models adjusted for clinical covariates were used to assess fracture risk across tertiles of each marker and BMD category. Time-dependent receiver operating characteristic (ROC) curves were used to compare predictive performance for 5-year fracture risk. Results: Fracture risk did not differ significantly across tertiles of PTH, CTX, or bone ALP in either RRT or non-RRT groups. Spline analysis likewise demonstrated no meaningful nonlinear associations. In contrast, BMD was significantly associated with fracture risk in both groups: patients with osteoporosis (T-score ≤ −2.5) had markedly elevated risk in the RRT (adjusted HR 17.7, 95% CI 2.24–2288.2) and non-RRT (HR 14.5, 95% CI 1.80–1885.3) groups. Time-dependent ROC analysis confirmed the superior predictive performance of BMD over BTMs for 5-year fracture risk, with AUCs of 0.712 (RRT) and 0.641 (non-RRT). No BTM outperformed BMD in either group. Conclusion: BMD was a strong predictor of fracture risk in CKD patients, regardless of dialysis status. In contrast, bone turnover markers were not associated with fracture risk. These results support the role of BMD assessment in fracture risk evaluation in CKD.Time-dependent ROC Curves for 5-year fracture risk prediction in RRT (left) and non-RRT (right) patients.

Journal of the American Society of NephrologyVol. 36(10S)
Korea University Medical Center (KR)
Openalex Percentile: Top 61%
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fracture Risk Prediction in CKD: Comparing Bone Turnover Markers and Bone Mineral Density (BMD) Performance in Dialysis and Nondialysis Populations — Ji Eun Kim · Journal of the American Society of Nephrology (2025) | TGRS Research Map | TGRS